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Background: Left atrium enlargement has been associated with cardiac events in patients with mitral regurgitation
(MR). Left atrium reverse remodeling (LARR) occur after surgical correction of MR, but the preoperative predictors of
this phenomenon are not well known. It is therefore important to identify preoperative predictors for postoperative
LARR.
Methods: We enrolled 62 patients with chronic severe MR (prolapse or flail leaflet) who underwent successful
mitral valve surgery (repair or replacement); all with pre- and postoperative echocardiography. LARR was defined as
a reduction in left atrium volume index (LAVI) of ≥25%. Stepwise multiple regression analysis was used to identify
independent predictors of LARR.
Results: LARR occurred in 46 patients (74.2%), with the mean LAVI decreasing from 85.5 mL/m2 to 49.7 mL/m2
(p <0.001). These patients had a smaller preoperative left ventricular systolic volume (p =0.022) and a higher left
ventricular ejection fraction (LVEF) (p =0.034). LVEF was identified as the only preoperative variable significantly
associated with LARR (odds ratio, 1.086; 95% confidence interval, 1.002–1.178). A LVEF cutoff value of 63.5% identified
patients with LARR of ≥25% with a sensitivity of 71.7% and a specificity of 56.3%.
Conclusions: LARR occurs frequently after mitral valve surgery and is associated with preoperative LVEF higher
than 63.5%.
Keywords: Mitral valve insufficiency, Mitral valve surgery, Left atrial remodeling, Left atrial volumeIntroduction
Both left atrial enlargement and remodeling are
compensatory mechanisms in patients with chronic
severe mitral regurgitation (MR). These changes
allow the left atrium to accommodate the regurgitant
volume without increased pressure [1-3]. It is recognized
that left atrial enlargement is a marker of major
cardiovascular events such as atrial fibrillation, stroke,
and death in patients with cardiac disease [4-8]. In
patients with chronic severe MR, left atrial size seems to
be an important predictor of outcome, either during* Correspondence: vmoises@unifesp.br
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[3,9-11]. A decrease in left atrial size, or reverse
remodeling, has been observed after mitral valve
surgery [12-17]. These prior studies included patients
with different causes of MR, analyzed left atrial size
using different techniques, and found different pre- and
postoperative factors related to postoperative left atrial
reverse remodeling (LARR). Different definitions of LARR
after MR surgery have also been used; some considered
any reduction value and others no more than 15% [12-17].
Low values may be very sensitive and may not have great
hemodynamic meaning. We hypothesized that larger post-
operative LARR would represent a stronger hemodynamic
impact by surgery and have different predictor factors. The
objectives of our study were to assess the changes in left
atrial size after surgery for MR and to verify the preoperativeal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Baseline patient characteristics
Variables n (%)
Male sex 37 (59.7)
Body surface area (m2); mean ± SD 1.73 ± 0.19
Stage 1 systemic hypertension 37 (59.7)
Rhythm:
Sinus 50 (80.6)
Atrial fibrillation 12 (19.4)
Functional class:
II 43 (69.4)
III / IV 19 (30,6)
Medications:
Diuretic 54 (84.4)
ACE inhibitor 38 (59.4)
Βeta blocker 25 (39.1)
Calcium channel blocker 9 (14.1)
Digoxin 9 (14.1)
Amiodarone 1 (1.6)
Aspirin 13 (20.3)
Oral anticoagulant 3 (4.7)
ACE: angiotensin converter enzyme; SD: standard deviation.
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of a reduction in left atrial volume index (LAVI) of at
least 25%.
Methods
Patients
We prospectively enrolled 62 patients with degenerative
(prolapse or flail leaflet) chronic severe MR who were
scheduled to undergo mitral valve surgery (repair or
replacement). The ethical committee review board of
both participating institutions approved the study, and
all patients provided informed consent (Research Ethical
Committee: Escola Paulista de Medicina and Instituto
Dante Pazzanese de Cardiologia). Patients were excluded
if they had functional or acute MR, associated moderate
or severe disease of another cardiac valve, coronary artery
disease, congenital heart disease, infective endocarditis,
acute rheumatic fever, stage 2 or 3 systemic hypertension,
or a past history of mitral-valve surgery. Patients who had
greater than mild MR after surgery were also excluded.
Pre- and postoperative assessment included the patients’
clinical history, physical examination, electrocardiography,
chest radiography, and echocardiography. Recommendations
for coronary angiography and mitral-valve surgery
(valvular repair vs. replacement) were made according
to international guidelines [18,19].
Echocardiography
All patients had a comprehensive transthoracic echocardio-
gram prior to surgery (Vivid7®; GE Vingmed Ultrasound,
Horton, Norway), using a 2–4 MHz multifrequential
transducer. Echocardiography was repeated between 2
and 10 months after surgery. Patient position, echo-
cardiographic imaging planes, and measures were
performed as recommended by the American Society of
Echocardiography [20]. Two experienced echocardiog-
raphers acquired and analyzed all images. The left
ventricular diastolic and systolic diameters were measured
using M-mode or 2-dimensional echocardiography. The
left ventricular systolic volume, diastolic volume, and
ejection fraction (LVEF) were obtained using the biplane
Simpson method. The left atrial volume was estimated
using the biplane area-length method and expressed in
milliliters (mL). LAVI was determined by dividing left
atrial volume (mL) by body surface area (m2). LARR was
defined as a reduction of ≥25% in LAVI on postoperative
echocardiography.
The morphologic and functional characteristics of the
mitral valve were analyzed to determine the etiology of
each patient’s disease. The severity of MR was estimated
using the flow convergence method [21]. Severe MR
was defined as a regurgitant volume ≥60 mL/beat and
an effective regurgitant orifice area ≥0.40 cm2. For all
measurements, diastole was defined as the beginningof the QRS complex, and systole was defined as the
peak of the T wave in the same cardiac cycle. The final
value of each variable was the mean of 3 measurements in
different cardiac cycles.
Statistical analysis
Continuous variables are presented as mean values ±
standard deviation, and categorical variables as absolute
numbers and percentages. The normal distribution of con-
tinuous variables was analyzed using the Kolmogorov-
Smirnov test. The association between categorical variables
was assessed using either Pearson’s chi-square or Fisher’s
exact test. To compare preoperative and postoperative
variables, the paired Student’s t-test or the Wilcoxon
test, were used. Comparison between groups with and
without LARR was done using either Student’s t-test
or the Mann–Whitney test. Stepwise multiple regression
analysis using the backward elimination method was used
to determine preoperative variables associated with LARR.
The Yolden criteria were used to identify the cutoff value
of LVEF that predicted LARR ≥25% [22]. Intra- and inter-
observer variability was assessed by means of percentual
difference between measurements, the paired t-test, and
the Pearson correlation coefficient. The significance level
of all tests was set at 5%.
Results
The baseline characteristics of the patients are presented
in Table 1. Thirty-four patients (54.8%) underwent mitral
Table 3 Comparison of age and preoperative
echocardiographic variables of patients with or without
postoperative left atrium reverse remodeling
Variable LAVI reduction <25%
(n = 16)
LAVI reduction ≥25%
(n = 46)
p-value
Age (years) 50.3 ± 17.3 53.3 ± 14.3 0.42
LAVI (mL/m2) 77.3 ± 39 88.4 ± 36 0.15
LVdD (mm) 61,6 ± 5.4 60.8 ± 5.3 0.75
LVsD (mm) 39.8 ± 5.0 37.8 ± 5.1 0.25
LVdV (mL) 151 ± 46 128 ± 37 0.050
LVsV (mL) 60 ± 28 42 ± 20 0.022
LVEF (%) 63 ± 9.0 67 ± 6.7 0.034
RV (mL) 88 ± 27 96 ± 45 0.88
EROA (cm2) 0.56 ± 0.18 0.60 ± 0.24 0.83
Values given as mean ± standard deviation.
EROA: effective regurgitant orifice area; LAVI: left atrium volume index; LVdD:
left ventricle diastolic diameter; LVsD: left ventricle systolic diameter; LVdV: left
ventricle diastolic volume; LVsV: left ventricle systolic volume; LVEF: left
ventricle ejection fraction; RV: mitral valve regurgitant volume per beat.
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using 19 biological and 9 mechanical prostheses. Surgical
atrial reduction was not performed in any patients
included in the study. In the postoperative evaluation, 52
patients were in sinus rhythm, and 10 in atrial fibrillation.
Sixty (98.8%) patients had a preoperative LAVI ≥40 mL/m2.
The LAVI decreased from a preoperative mean of
85.5 mL/m2 to a postoperative mean of 49.6 mL/m2
(p <0.001); the mean reduction was 39%. LARR was
observed in 46 (74.2%) patients.
Categorical variables such as sex, age ≥ or <50 years
old, the presence or absence of systemic hypertension,
functional class of I/II or III/IV, type of surgery performed
(repair or replacement), postoperative mean diastolic
gradient and preoperative cardiac rhythm (sinus or atrial
fibrillation) were not significantly associated with
LARR, with p-values ranging from 0.14 to 1.0. All
echocardiographic variables, including LVEF, decreased
significantly after surgery, but the difference in left
ventricular systolic volume was not statistically significant
(Table 2). Patients with LARR had smaller preoperative
left ventricular systolic volume values and higher LVEF
values (p =0.022, 0.034, respectively); other preopera-
tive variables were not significantly different between
patients with or without LARR (Table 3). Stepwise multiple
regression analysis revealed that LVEF was the only pre-
operative variable significantly associated with LARR (odds
ratio, 1.086; 95% confidence interval, 1.002–1.178). A cutoff
value of 63.5% for preoperative LVEF identified patients
with LARR ≥25% after surgery, with a sensitivity of 72%
and a specificity of 56%.
Analysis of intra- and interobserver variability showed a
high and significant correlation in LAVI measures (r =0.97;
p <0.0001) with a mean difference of 8.7% (p =0.10). The
mean difference between the 2 LAVI measurements by the
same observer was 9.3% (p =0.10) and the measurements
were highly correlated (r =0.98; p <0.0001).
Discussion
We found that LARR occurs frequently after surgery for
chronic severe MR and that preoperative LVEF is theTable 2 Echocardiographic variables
Variables Before surgery After surgery P-value
LAVI (mL/m2) 85.5 ± 36.8 49.7 ± 25.1 < 0.001
LVdD (mm) 61.0 ± 5.3 52.4 ± 5.5 < 0.001
LVsD (mm) 38.3 ± 5.2 35.3 ± 6.0 < 0.001
LVdV (mL) 133.8 ± 40.1 98.2 ± 32.1 < 0.001
LVsV (mL) 46.5 ± 23.3 41.6 ± 19.8 0.23
LVEF (%) 66.1 ± 7.5 59.1 ± 9.1 < 0.001
Values given as mean ± standard deviation.
LAVI: left atrium volume index; LVdD: left ventricle diastolic diameter; LVsD:
left ventricle systolic diameter; LVdV: left ventricle diastolic volume; LVsV: left
ventricle systolic volume; LVEF: left ventricle ejection fraction.only variable significantly associated with a postoperative
LAVI reduction of at least 25%.
The percentage of patients in our study with LARR
after mitral valve repair or replacement is similar to
other study populations previously described [12-17].
Many factors have been reported as determinants of
LARR after mitral regurgitation surgery. These include
MR etiology, patient age, preoperative LAVI, cardiac
rhythm, mitral valve double dysfunction with predominant
MR, systemic arterial pressure, diastolic mitral pressure
gradient, postoperative reduction in left ventricle diastolic
volume, and residual mitral regurgitation after surgery
[13-17]. Prior studies differed from ours regarding the
etiology of MR, the criteria used to define LARR, the
techniques used to analyze left atrial size, and the statistical
methods employed. In our study, a preoperative LVEF of
63.5% or higher identified those patients with at least
25% LARR. This is interesting, since LVEF in MR is
an important prognostic factor for postoperative LVEF
and functional class, and a determinant for surgical
correction in asymptomatic patients. A LVEF of 63.5%
is close to the 60% recommended as the threshold for
surgery in most guidelines and similar to the finding
of a recently published study [18,19,23,24].
Left atrial size in patients with chronic mitral regurgita-
tion increases with the severity of the regurgitant volume
and with the duration and progression of the disease
[1-3]. Also influencing left atrial dilation, LVEF is known
to deteriorate in patients with advanced MR, and diastolic
dysfunction may occur [2,3]. As long as left atrial dilation
persists or progresses, interstitial wall fibrosis and
hypertrophy may develop and make reversal remodeling
after surgery less likely [25-27] This may be a reason for
the observed association of better preoperative LVEF
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mitral-valve surgery with reduction in left ventricular
volume, a decline in left ventricular filling pressure
may have occurred, facilitating left atrium emptying
and reverse remodeling.
As suggested by recent study, reducing mitral-
regurgitation volume may be an important determinant
of LARR after mitral-valve intervention [23]. This may
have been an important reason for the observed LAVI
reduction in the present study, since all patients had
severe preoperative regurgitant volume and no more
than mild postoperative mitral regurgitation. These were
predefined conditions to select patients for the study
and may explain why both were not associated to LARR.
Some studies define LARR as a reduction of at least
15% in LAVI, but others do not define a cutoff value
[12-17]. Failing to use a criterion, or using an inadequate
cutoff value, may mean that the observed reduction fell
within the range of inter- and intraobserver variability,
or that the reduction had a small degree of clinical
significance and consequently influenced both the
quantitative identification of LARR and the determination
of predictor factors. Our use of a reduction in LARR of at
least 25% may have been important in the search for
preoperative predictors. This value, higher than that
used in other studies, was able to overcome the intra- and
interobserver variability in left atrium volume measures
and may therefore be more clinically relevant.
Considering the known association between increased
left atrial size and cardiac events in patients with MR
[10,11] and the fact that early surgery may avoid excess
left atrial dilation, it seems reasonable to point out that
LARR after MR surgery may be beneficial. A recent large
multicenter study using propensity-score matching
found that early surgery in patients with MR due to flail
leaflets was associated with less heart failure and lower
mortality than medical management. However, there was
no difference in atrial fibrilation, which is usually associated
with a large left atrium [28]. In our study, preoperative
atrial fibrillation was not associated with postoperative
LARR; of 12 patients with preoperative atrial fibrillation,
2 recovered sinus rhythm after surgery. Another retro-
spective study did not find association between LARR and
reduction of cardiovascular events, mortality and atrial
fibrillation [29]. Further studies are needed to verify the
prognostic benefits of LARR after mitral-valve surgery in
patients with MR.
Study limitations
The time between postoperative echocardiography and
surgery was relatively short in our study. Because of our
method of patient selection, the results of this study may
not be applicable to patients with MR from other causes,
to patients with acute mitral insufficiency or to thosewith more than mild residual MR. Despite in our study
the type of surgery was not related to LARR, a finding
similar to other study [16], due to relative small number
of patients and variations in type and size of prosthetic
valves, we were not able to analyze separately patients
who underwent mitral valve repair or replacement. Finally,
3-dimensional echocardiography was not used in our
study, although it seems to be slightly more precise for
determining LA volume compared with 2-dimensional
echocardiography, and facilitates functional analysis.
Conclusion
In patients with primary chronic severe MR, LARR
occurs frequently after valvular surgery and is associated
with the preoperative LVEF higher than 63.5%.
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